A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...

In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

News headlines often compress complex science into a simple storyline: If two things are happening at the same time, one must ...

Far Far West's frantic gunfights earn a hearty yeehaw from me.

An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...

New findings show how inherited and acquired genetic mutations cause breast cancer resistance to CDK4/6 inhibitors.

Transcript: Rare Diseases ...

Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...

The University of Warwick, which is setting up the Registry, plans to collect data for analysis from 500 AML patients at sites in 30 large metropolitan NHS hospitals across the UK by the end of this ...

Good morning, and welcome to Ocugen's Fourth Quarter and Full Year 2025 Financial Results and Business Update [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...